市場調査レポート
商品コード
1114702
尿道狭窄治療装置の世界市場:現状分析と予測(2021年~2027年)Urethral Stricture Treatment Devices Market: Current Analysis and Forecast (2021-2027) |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
尿道狭窄治療装置の世界市場:現状分析と予測(2021年~2027年) |
出版日: 2022年06月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 229 Pages
納期: 即日から翌営業日
|
世界の尿道狭窄治療装置の市場規模は、予測期間(2021年~2027年)中に約6%のCAGRで成長すると予測されています。
尿道狭窄治療装置の採用が拡大している背景には、前立腺肥大症や神経因性膀胱の有病率の上昇と、急速に増加する高齢者人口の増加が挙げられます。さらに、技術の急速な進歩も尿道狭窄治療装置市場を牽引すると考えられます。
当レポートでは、世界の尿道狭窄治療装置市場について調査しており、市場の洞察、市場動向、競合シナリオ、企業概要など、包括的な情報を提供しています。
Global Urethral Stricture Treatment Devices Market is anticipated to grow with an elevated CAGR of around 6% over the forecast period (2021-2027).
Urethral stricture is a condition in which the urethral opening becomes narrow due to injuries, scars, or infection. A stricture obstructs the free flow of the urine through the urethra. Therefore, urethral stents, catheters, or dilators are employed to maintain the flow as the urethral stricture treatment. The growing adoption of urethral stricture treatment devices can be attributed to the rising prevalence of benign prostatic hyperplasia & neurogenic bladder coupled with a rapidly growing geriatric population. According to the United Nations, the 60+ aged population was 962 million in 2017 which is more than twice that it was in 1980 at 382 million. The number of elderly people is expected to double again by 2050 and reach nearly 2.1 billion worldwide. Furthermore, with rapid advancements in technology, many of the industry players are focusing on launching new products in the market to expand their product portfolio, which will drive the market for urethral stricture treatment devices globally. For example, in December 2021, The US Food and Drug Administration (FDA) approved the Urotronic Optilume Urethral Drug Coated Balloon to treat urethral strictures in males. It serves as an alternative to traditional endoscopic stricture treatments for men suffering from urethral strictures. Boston Scientific Corporation, Laborie, Cook Medical, B.Braun Melsungen AG, Allium Medical, Becton, Dickinson and Company, Teleflex Incorporated, Pnn Medical A/S, Med pro Medical B.V., and Coloplast, are some of the prominent players operating in the urethral stricture treatment devices market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with urethral stricture treatment devices.
Insights Presented in the Report
"Amongst Product Type, urethral balloon dilation catheters segment holds the major share"
Based on product type, the urethral stricture treatment devices market is segmented into urethral dilators, urethral stents, urethral balloon dilation catheters, and urinary catheters. The urethral balloon dilation catheters segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe as it is well-tolerated, safe, and offers various advantages such as minimal complications, less morbidity, and technically less challenging to perform.
"Amongst Stricture Location, anterior segment holds the major share"
Based on stricture location, the urethral stricture treatment devices market is divided into anterior and posterior. The anterior segment occupied the major share of the urethral stricture treatment devices market in 2020 and it is expected to grow with a substantial CAGR in the upcoming years as anterior urethral strictures are the most common and occur anywhere along the urethra from the urethral meatus at the tip of the penis, in the penile urethra or in the bulbar urethra, which is located behind the scrotum in males.
"Amongst End-Users, hospitals segment holds the major share"
Based on end-users, the market is fragmented into hospitals, specialty clinics, and others. In 2020, the hospitals segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the increasing number of hospitals and a surge in the number of urology surgeries in the hospital setting. Also, the presence of well-trained healthcare professionals, well-established infrastructure, and availability of technologically advanced devices in hospitals are some of the factors contributing to the growth of this segment. However, specialty clinics are also likely to witness lucrative growth during the forecast period.
"North America represents one of the largest markets of Urethral Stricture Treatment Devices market"
For a better understanding of the market dynamics of the Urethral Stricture Treatment Devices market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the urethral stricture treatment devices market industry in 2020 owing to the strong healthcare infrastructure and growing adoption of urethral stricture treatment devices in the region.
Reasons to buy this report:
The study includes market sizing and forecasting analysis validated by authenticated key industry experts
The report presents a quick review of overall industry performance at one glance
The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
The study comprehensively covers the market across different segments
Deep dive regional level analysis of the industry
Customization Options:
The global urethral stricture treatment devices market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.